ロード中...
SPHK1在调节小细胞肺癌多药耐药中的作用
BACKGROUND AND OBJECTIVE: Lung cancer is the leading cause of cancer-related deaths worldwide. Approximately 15% of all histological types consist of small cell lung cancer (SCLC). Chemotherapy is one of the major treatment method. Though the current first-line standard chemotherapy regimen for SCLC...
保存先:
| 出版年: | Zhongguo Fei Ai Za Zhi |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
中国肺癌杂志编辑部
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000353/ https://ncbi.nlm.nih.gov/pubmed/25404266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2014.11.01 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|